A11154
Size
  • 50ul
  • 100ul
Price
  • $129
  • $229
Qty
Product description

breast cancer anti-estrogen resistance 3(BCAR3) Homo sapiens Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estroge

Source
Rabbit
Applications
WB,IHC,IF,ELISA
Reactivity
Human
Dilution
WB: 1/500 - 1/2000. IHC: 1/100 - 1/300. IF: 1/200 - 1/1000. ELISA: 1/10000. Not yet tested in other applications.
Storage
-20°C/1 year
Specificity
BCAR3 Polyclonal Antibody detects endogenous levels of BCAR3 protein.
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized peptide derived from human BCAR3. AA range:761-810
Uniprot No
O75815
Alternative names
BCAR3; NSP2; SH2D3B; Breast cancer anti-estrogen resistance protein 3; Novel SH2-containing protein 2; SH2 domain-containing protein 3B
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
breast cancer anti-estrogen resistance 3(BCAR3) Homo sapiens Breast tumors are initially dependent on estrogens for growth and progression and can be inhibited by anti-estrogens such as tamoxifen. However, breast cancers progress to become anti-estroge
Other
Gene_name: BCAR3 ; Protein_name: Breast cancer anti-estrogen resistance protein 3; Expression: Epithelium,Kidney,Lung,Testis,
Mol.Wt (Da)
92 kD
Concentration
1 mg/ml